Meningioma
📧 Sign up to get email alerts when something new happens for Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-26Clinical Trial Update: A Study of ONC201 for Refractory Meningioma [Phase 2]
A Phase 2 study of ONC201 for refractory meningioma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-25Clinical Trial Update: Dosimetry Guided PRRT With 90Y-DOTATOC [Phase 2]
A Phase 2 trial evaluating dosimetry-guided peptide receptor radionuclide therapy using 90Y-DOTATOC has been withdrawn. The study covered ne…
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors [NA]
A clinical trial evaluating 68Ga-DOTATOC PET-CT for brain tumors in children and young adults has been withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2012-04-24Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
A clinical trial investigating Vascular Endothelial Growth Factor (VEGF) levels in brain tumor patients has been withdrawn.